breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed diagnosis of breast cancer by laboratory and clinical evidence Hemoglobin > 8 g/dL Hematocrit > 30% SGOT serum level <3 times higher than normal Bilirubin level less than 2 mg/dl Creatinine less than 2mg/dl Normal thyroid test result
Exclusion criteria
Exclusion criteria: Having an underlying and chronic active inflammatory disease such as: RA, COPD, unstable cardiovascular disease, lung diseases such as asthma, uncontrolled pain, severe infection, pregnancy, severe depression Simultaneous use of drugs that can affect fatigue Metastatic patients with poor performance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms of fatigue. Timepoint: Measurement of symptoms of fatigue before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires.;Severity of symptoms of weakness. Timepoint: Measurement of symptoms of weakness before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences